Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells-Reference-Cited by-同舟云学术

Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells

Published:2002-03 Issue:3 Volume:9 Page:296-307
ISSN:0929-1903
Container-title:Cancer Gene Therapy
language:en
Short-container-title:Cancer Gene Ther

Author:

Scotlandi Katia,Maini Cecilia,Manara Maria Cristina,Benini Stefania,Serra Massimo,Cerisano Vanessa,Strammiello Rosaria,Baldini Nicola,Lollini Pier-Luigi,Nanni Patrizia,Nicoletti Giordano,Picci Piero

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/7700442.pdf

Reference39 articles.

1. Delattre O, Zucman J, Melot T et al. The Ewing family of tumors — a subgroup of small-round-cell tumors defined by specific chimeric transcripts N Engl J Med 1994 331: 294–299

2. Ambros IM, Ambros PF, Strehl S, Kovar H, Gadner H, Salzer Kuntschik M . MIC2 is a specific marker for Ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration Cancer 1991 67: 1886–1893

3. Kovar H, Dworzak M, Strehl S et al. Overexpression of the pseudoautosomal gene MIC2 in Ewing's sarcoma and peripheral primitive neuroectodermal tumor Oncogene 1990 45: 1067–1070

4. Campanacci M . Bone and Soft Tissue Tumors 2nd ed Wien: Springer-Verlag 1999

5. Bacci G, Toni A, Avella M et al. Long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy Cancer 1988 63: 1477–1486

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting of AKT-Signaling Pathway Potentiates the Anti-cancer Efficacy of Doxorubicin in A673 Ewing Sarcoma Cell Line;BioNanoScience;2021-09-04

2. Tumor levels of the mediators of ErbB2-driven anoikis resistance correlate with breast cancer relapse in patients receiving trastuzumab-based therapies;Breast Cancer Research and Treatment;2021-03-16

3. The Role of Tyrosine Kinases as a Critical Prognostic Parameter and Its Targeted Therapies in Ewing Sarcoma;Frontiers in Cell and Developmental Biology;2020-07-09

4. Precision Medicine in Soft Tissue Sarcoma Treatment;Cancers;2020-01-16

5. Mek activity is required for ErbB2 expression in breast cancer cells detached from the extracellular matrix;Oncotarget;2017-10-31